Breaking News

NextPharma Adds Executive

May 16, 2013

Cuiné joins the management team

Jean Cuiné has been appointed to the executive management team at NextPharma Technologies. Dr. Cuiné joins the company from Novartis, where he held a number of senior roles in Chemistry Manufacturing and Controls (CMC) development.
“I am extremely pleased to be welcoming Jean to NextPharma, as his expertise and background will complete and further strengthen our senior management team,” said Franck Latrille, chief executive officer. “In this new role, Jean will be instrumental in driving forward our product development services on a global scale.”
Dr Cuiné said, “I am truly excited about joining NextPharma. I already see great potential in the strength of technical expertise and the existing team of highly talented scientists at NextPharma. My priority is to grow a successful product development function that will develop and add to this talent, promoting creativity and innovation for the benefit of our customers.”
  • Patheon Furthers Expansion Strategy

    Kristin Brooks, Contract Pharma||January 9, 2017
    Patrick Glaser of Patheon discusses expanded manufacturing capacity, capabilities, and future plans

  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • Setting a Precedent for Biosimilars in the U.S.

    Setting a Precedent for Biosimilars in the U.S.

    Kristin Brooks, Contract Pharma||May 19, 2015
    Niall Dinwoodie of Charles River discusses several key industry issues on biosimilars and addresses some of the development and regulatory hurdles that remain

  • Limiting APIs in Manufacturing Effluent

    Limiting APIs in Manufacturing Effluent

    Joan Tell, Robert Drinane, Bruce Naumann, Jessica Vestel, and Gregory Gagliano, Merck & Co., Inc.||June 2, 2016
    An approach for setting limits on pharmaceuticals discharged in manufacturing effluent

  • Biopharma CMO Market Trends

    Biopharma CMO Market Trends

    Tim Wright, Editor||June 2, 2016
    Continued strong growth in biopharma industry is being driven by biosimilars

  • Continuous Pharmaceutical Processes and Their Demands

    Continuous Pharmaceutical Processes and Their Demands

    Girish Malhotra, EPCOT International||April 5, 2016
    A look at the unique characteristics of continuous processes in pharmaceutical manufacturing.